MarketScreener Strategies Vertex Pharmaceuticals Incorporated

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-02 EDT			5-day change	1st Jan Change
528.04 ^USD	+6.03%		+7.47%	+16.47%

07-02	Vertex Pharmaceuticals Incorporated Receives Us Fda Approval for Expanded Use of Casgevy for Treatment of People Ages 2 Years and Older with Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	CI
07-02	Vertex Pharmaceuticals Says FDA Approves Expanded Use of Casgevy in Younger Children With Blood Disorders	MT

	Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease	December 11, 2023 at 05:47 am
	Vertex Pharmaceuticals Incorporated : Confirms growth trajectory	May 04, 2023 at 09:35 am
	Vertex Pharmaceuticals : A very promising pipeline	January 11, 2023 at 05:20 am